NCT02010021
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
- Locations
-
- Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States
Clinical trial condition
Breast Neoplasms
Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.
9,877 public trials
1,785 recruiting studies
Breast Neoplasms trial results
NCT02418624
- Conditions
- Adnexal Diseases, Advanced Cancer, Breast Cancer, +20 more
- Locations
-
- Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital Amsterdam, Netherlands
NCT03470935
- Conditions
- Breast Cancer Female, Breast Diseases, Breast Neoplasms, +4 more
- Locations
-
- Centre investigateur CARIO-HPCA Plérin, France
NCT01795612
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
- Locations
-
- University Hospital, Limoges Limoges, France
Completed
Combined Training Intervention for Women Who Underwent Primary Treatment for Breast Cancer
NCT03124095
- Conditions
- Behavior, Breast Diseases, Breast Neoplasm, +6 more
- Locations
-
- Physical Education School Pelotas, Rio Grande do Sul, Brazil
NCT01460186
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +9 more
- Locations
-
- Hôpital Jean Minjoz - CHU Besançon Besançon, France
- Institut Bergonié Bordeaux, France
- Centre François Baclesse Caen, France
- Centre Georges François Leclerc Dijon, France
NCT01383174
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
- Locations
-
- Multiple Locations, California, United States
NCT00148681
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Center Boston, Massachusetts, United States
NCT02585362
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +49 more
- Locations
-
- Kantonsspital Winterthur Winterthur, Switzerland
Completed
Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors
NCT01286987
- Conditions
- Adnexal Diseases, Advanced or Recurrent Solid Tumors, Breast Diseases, +49 more
- Locations
-
- Scottsdale Healthcare Scottsdale, Arizona, United States
- Virginia G. Piper Cancer Center Research Pharmacy Scottsdale, Arizona, United States
- (IRB# 12-000131) Ronald Reagan UCLA Medical Center, Drug Information Center Los Angeles, California, United States
- Ronald Reagan UCLA Medical Center Los Angeles, California, United States